Friday, July 10, 2026

Drug profile · INN

irinotecan hydrochloride liposome injection

irinotecan hydrochloride liposome injection is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — irinotecan hydrochloride liposome injection
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

irinotecan hydrochloride liposome injection is an FDA-listed pharmaceutical active ingredient.

Key facts

INN irinotecan hydrochloride liposome injection

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. ES-2024-072-02 Unknown · First People's Hospital · Small Cell Lung Cancer
  2. irinotecan hydrochloride liposome injection Unknown · Chinese Academy of · Biliary Tract Carcinoma

Frequently asked questions

What is irinotecan hydrochloride liposome injection?

irinotecan hydrochloride liposome injection is an FDA-listed pharmaceutical active ingredient.